SCHEMBL7321027

SCHEMBL7321027

CCOC(=O)[C@H](Cc1ccc(OC2CCN(C)CC2)cc1)N(C(=O)[C@H]1NC(C)(C)CS1)S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.34
HRH1 P35367 3/20 0.34
CCR3 P51677 3/20 0.34
KCNH2 Q12809 2/20 0.34
F10 P00742 4/20 0.33
PLG P00747 4/20 0.33
PRSS1 P07477 4/20 0.33
PRSS2 P07478 4/20 0.33
PRSS3 P35030 4/20 0.33
HTR2A P28223 3/20 0.33
F2 P00734 3/20 0.33
HTR2C P28335 2/20 0.33
ACACB O00763 1/20 0.33
FPR2 P25090 1/20 0.33
PROKR1 Q8TCW9 1/20 0.33
ALDH1A1 P00352 2/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7323301 0.93 HRH1 (0.38) CYP2D6HRH1CCR3KCNH2HTR2A
SCHEMBL7189923 0.86 POLB (0.34) ALDH1A1TP53ALOX15MAPK1NPSR1
SCHEMBL6712432 0.83 MAPK1 (0.38) ALDH1A1PKMTP53ALOX15MAPK1
SCHEMBL7318412 0.82 ALDH1A1 (0.37) ALDH1A1PKM
SCHEMBL6709476 0.82 MAPT (0.46) ALDH1A1PKMTP53MAPK1NPSR1
SCHEMBL3852759 0.80 P2RX7 (0.37) ALDH1A1TP53ALOX15MAPK1NPSR1
SCHEMBL3848898 0.80 ITGB1 (0.38) ALDH1A1TP53ALOX15MAPK1NPSR1
SCHEMBL7314567 0.79 CYP2D6 (0.34) CYP2D6HRH1CCR3KCNH2F10
SCHEMBL7174955 0.77 KMT2A (0.42) ALDH1A1PKMTP53MAPK1NPSR1
SCHEMBL6714501 0.77 CA9 (0.38) ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP claimed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO claimed
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US disclosed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP disclosed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed